“autoimmune-disease” Archives

in
Entry Author Date Location
Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup 02/04/20 New York
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
Kymera Adds $65M in New Funding and Eyes First Clinical Test 11/13/18 Boston
Celsius Snags $65M to Harness Single-Cell Genomics for Drug Discovery 05/15/18 Boston
Roche Buys Inception 5 MS Program, Versant Funds New Venture 04/04/18 San Diego
Rheos Medicines Launches, Backed by $60M for Immunometabolism R&D 03/22/18 Boston
Xconomy Bookclub: “Inferior” Peruses Science’s Historic #MeToo Bias 02/01/18 National
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Syntimmune Snares $50M to Test Autoimmune Drug in Two Rare Diseases 06/21/17 New York
Invictus Medical, Under Temporary CEO, Pushes Sales and New Products 07/19/16 Texas
San Antonio’s Invictus Medical Board Member Replaces Roberts as CEO 07/06/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Key for Houston’s Biotech Ecosystem? Building a Bench of Executives 12/07/15 Texas
With Termeer Aboard, Artax Tries New Attack On Autoimmune Disease 09/22/15 Boston
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up 05/12/14 San Francisco
Using Frugal Business Model, Orphagen Targets Orphan Receptors 06/13/13 San Diego
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Angry at the Genome 01/25/12 Boston
Coronado Biosciences Files Form 10 07/18/11 New York
Coronado Biosciences Pulls in $25.8 Million 07/06/11 New York
Acetylon Pharma Raises $12.4M 02/22/11 Boston
XDx, After a Long Slog in Molecular Diagnostics, Predicts First Profit in 2011 12/21/10 San Francisco
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
$20M Series A For Karyopharm to Fight Cancer 11/03/10 Boston
Where Will the New Disease Treatments Come From a Decade From Now? 07/15/10 San Francisco
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Page 1 of 2 next page »